Literature DB >> 25486199

Indole-3-carbinol and its N-alkoxy derivatives preferentially target ERα-positive breast cancer cells.

Joseph A Caruso1, Rody Campana, Caimiao Wei, Chun-Hui Su, Amanda M Hanks, William G Bornmann, Khandan Keyomarsi.   

Abstract

Indole-3-carbinol (I3C) is a natural anti-carcinogenic compound found at high concentrations in Brassica vegetables. I3C was recently reported to inhibit neutrophil elastase (NE) activity, while consequently limiting the proteolytic processing of full length cyclin E into pro-tumorigenic low molecular weight cyclin E (LMW-E). In this study, we hypothesized that inhibition of NE activity and resultant LMW-E generation is critical to the anti-tumor effects of I3C. LMW-E was predominately expressed by ERα-negative breast cancer cell lines. However, ERα-positive cell lines demonstrated the greatest sensitivity to the anti-tumor effects of I3C and its more potent N-alkoxy derivatives. We found that I3C was incapable of inhibiting NE activity or the generation of LMW-E. Therefore, this pathway did not contribute to the anti-tumor activity of I3C. Gene expression analyzes identified ligand-activated aryl hydrocarbon receptor (AhR), which mediated sensitivity to the anti-tumor effects of I3C in ERα-positive MCF-7 cells. In this model system, the reactive oxygen species (ROS)-induced upregulation of ATF-3 and pro-apoptotic BH3-only proteins (e.g. NOXA) contributed to the sensitivity of ERα-positive breast cancer cells to the anti-tumor effects of I3C. Overexpression of ERα in MDA-MB-231 cells, which normally lack ERα expression, increased sensitivity to the anti-tumor effects of I3C, demonstrating a direct role for ERα in mediating the sensitivity of breast cancer cell lines to I3C. Our results suggest that ERα signaling amplified the pro-apoptotic effect of I3C-induced AhR signaling in luminal breast cancer cell lines, which was mediated in part through oxidative stress induced upregulation of ATF-3 and downstream BH3-only proteins.

Entities:  

Keywords:  AhR, aryl hydrocarbon receptor; CYP, cytochrome p450 oxidases; DIM, 3,3-diindoylmethane; ERα, estrogen receptor α; HMECs, human mammary epithelial cells; I3C, indole-3-carbinol; LMW-E, low molecular weight cyclin E; NE, neutrophil elastase; ROS, reactive oxygen species; RPPA, reverse phase protein array; TNBC, triple-receptor negative breast cancer; aryl hydrocarbon receptor; estrogen receptor α; indole-3-carbinol; neutrophil elastase

Mesh:

Substances:

Year:  2014        PMID: 25486199      PMCID: PMC4614451          DOI: 10.4161/15384101.2015.942210

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  58 in total

Review 1.  Molecular targets and anticancer potential of indole-3-carbinol and its derivatives.

Authors:  Bharat B Aggarwal; Haruyo Ichikawa
Journal:  Cell Cycle       Date:  2005-09-06       Impact factor: 4.534

2.  Reverse phase protein array: validation of a novel proteomic technology and utility for analysis of primary leukemia specimens and hematopoietic stem cells.

Authors:  Raoul Tibes; Yihua Qiu; Yiling Lu; Bryan Hennessy; Michael Andreeff; Gordon B Mills; Steven M Kornblau
Journal:  Mol Cancer Ther       Date:  2006-10       Impact factor: 6.261

3.  Indole-3-carbinol and tamoxifen cooperate to arrest the cell cycle of MCF-7 human breast cancer cells.

Authors:  C M Cover; S J Hsieh; E J Cram; C Hong; J E Riby; L F Bjeldanes; G L Firestone
Journal:  Cancer Res       Date:  1999-03-15       Impact factor: 12.701

4.  Indole-3-carbinol (I3C) induced cell growth inhibition, G1 cell cycle arrest and apoptosis in prostate cancer cells.

Authors:  S R Chinni; Y Li; S Upadhyay; P K Koppolu; F H Sarkar
Journal:  Oncogene       Date:  2001-05-24       Impact factor: 9.867

5.  Cdk2 is required for breast cancer mediated by the low-molecular-weight isoform of cyclin E.

Authors:  Said Akli; Carolyn S Van Pelt; Tuyen Bui; Laurent Meijer; Khandan Keyomarsi
Journal:  Cancer Res       Date:  2011-03-08       Impact factor: 12.701

6.  The aryl hydrocarbon receptor mediates degradation of estrogen receptor alpha through activation of proteasomes.

Authors:  Mark Wormke; Matthew Stoner; Bradley Saville; Kelcey Walker; Maen Abdelrahim; Robert Burghardt; Stephen Safe
Journal:  Mol Cell Biol       Date:  2003-03       Impact factor: 4.272

7.  Altered estrogen metabolism and excretion in humans following consumption of indole-3-carbinol.

Authors:  J J Michnovicz; H L Bradlow
Journal:  Nutr Cancer       Date:  1991       Impact factor: 2.900

8.  Effects of dietary indole-3-carbinol on estradiol metabolism and spontaneous mammary tumors in mice.

Authors:  H L Bradlow; J Michnovicz; N T Telang; M P Osborne
Journal:  Carcinogenesis       Date:  1991-09       Impact factor: 4.944

9.  Knockdown of aberrantly upregulated aryl hydrocarbon receptor reduces tumor growth and metastasis of MDA-MB-231 human breast cancer cell line.

Authors:  Gennifer D Goode; Billy R Ballard; H Charles Manning; Michael L Freeman; Yibin Kang; Sakina E Eltom
Journal:  Int J Cancer       Date:  2013-07-05       Impact factor: 7.396

10.  The dietary phytochemical indole-3-carbinol is a natural elastase enzymatic inhibitor that disrupts cyclin E protein processing.

Authors:  Hanh H Nguyen; Ida Aronchik; Gloria A Brar; David H H Nguyen; Leonard F Bjeldanes; Gary L Firestone
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-08       Impact factor: 11.205

View more
  10 in total

1.  Inhibition of oncogenic BRAF activity by indole-3-carbinol disrupts microphthalmia-associated transcription factor expression and arrests melanoma cell proliferation.

Authors:  Aishwarya Kundu; Jeanne G Quirit; Michelle G Khouri; Gary L Firestone
Journal:  Mol Carcinog       Date:  2016-02-15       Impact factor: 4.784

Review 2.  Role of dietary bioactive natural products in estrogen receptor-positive breast cancer.

Authors:  Min Ji Bak; Soumyasri Das Gupta; Joseph Wahler; Nanjoo Suh
Journal:  Semin Cancer Biol       Date:  2016-03-22       Impact factor: 15.707

Review 3.  Epigenetics of breast cancer: Modifying role of environmental and bioactive food compounds.

Authors:  Donato F Romagnolo; Kevin D Daniels; Jonathan T Grunwald; Stephan A Ramos; Catherine R Propper; Ornella I Selmin
Journal:  Mol Nutr Food Res       Date:  2016-06       Impact factor: 5.914

4.  Sequential Combination Therapy of CDK Inhibition and Doxorubicin Is Synthetically Lethal in p53-Mutant Triple-Negative Breast Cancer.

Authors:  Natalie A Jabbour-Leung; Xian Chen; Tuyen Bui; Yufeng Jiang; Dong Yang; Smruthi Vijayaraghavan; Mark J McArthur; Kelly K Hunt; Khandan Keyomarsi
Journal:  Mol Cancer Ther       Date:  2016-01-29       Impact factor: 6.261

5.  Combined Luteolin and Indole-3-Carbinol Synergistically Constrains ERα-Positive Breast Cancer by Dual Inhibiting Estrogen Receptor Alpha and Cyclin-Dependent Kinase 4/6 Pathway in Cultured Cells and Xenograft Mice.

Authors:  Xiaoyong Wang; Lijuan Zhang; Qi Dai; Hongzong Si; Longyun Zhang; Sakina E Eltom; Hongwei Si
Journal:  Cancers (Basel)       Date:  2021-04-27       Impact factor: 6.639

6.  A systems pharmacology approach based on oncogenic signalling pathways to determine the mechanisms of action of natural products in breast cancer from transcriptome data.

Authors:  Regan Odongo; Asuman Demiroglu-Zergeroglu; Tunahan Çakır
Journal:  BMC Complement Med Ther       Date:  2021-06-30

Review 7.  Teneurins: Role in Cancer and Potential Role as Diagnostic Biomarkers and Targets for Therapy.

Authors:  Giulia Peppino; Roberto Ruiu; Maddalena Arigoni; Federica Riccardo; Antonella Iacoviello; Giuseppina Barutello; Elena Quaglino
Journal:  Int J Mol Sci       Date:  2021-02-26       Impact factor: 5.923

8.  Current results on the biological and pharmacological activities of Indole-3-carbinol.

Authors:  Jae Kwang Kim; Sang Un Park
Journal:  EXCLI J       Date:  2018-02-06       Impact factor: 4.068

Review 9.  Structure-Based Classification and Anti-Cancer Effects of Plant Metabolites.

Authors:  Seong-Ah Shin; Sun Young Moon; Woe-Yeon Kim; Seung-Mann Paek; Hyun Ho Park; Chang Sup Lee
Journal:  Int J Mol Sci       Date:  2018-09-06       Impact factor: 5.923

Review 10.  Brassicaceae-Derived Anticancer Agents: Towards a Green Approach to Beat Cancer.

Authors:  Luigi Mandrich; Emilia Caputo
Journal:  Nutrients       Date:  2020-03-24       Impact factor: 5.717

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.